Blog
Mapping the Next Frontier of Immunotherapy: QSIT Expands Its Scientific Intelligence Program
Truway Health has expanded the scientific-intelligence framework supporting the Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study, identified as TWH-QSIT-IMMUNENET-2025-01 and NCT07221565.
The July 19, 2026 PubMed Intelligence Sweep broadens the study’s continuous monitoring across immunology, cellular metabolism, genetic engineering, cancer genomics, pharmacokinetics, pharmacovigilance, and international research governance.
Connecting Immune Signaling, Energy, and Geno
…
Jul 19th 2026
Understanding Interferon Response Pathways: Why Type I and Type III Interferons Matter in Modern Diagnostics and Product Development
June 22, 2026 | Truway Health Insights
The human immune system relies on an intricate communication network to recognize pathogens and coordinate protective responses. Among the most important signaling molecules involved in this process are interferons, a family of proteins that help cells detect and respond to viral infections and other biological stressors.
Understanding interferon biology is increasingly important for the future of diagnostics, laboratory medicine, regenerative therapies, an
…
Jun 22nd 2026